PL1667665T3 - Kapsułki zawierające peletki z substancją czynną z różnymi profilami uwalniania - Google Patents
Kapsułki zawierające peletki z substancją czynną z różnymi profilami uwalnianiaInfo
- Publication number
- PL1667665T3 PL1667665T3 PL04764591T PL04764591T PL1667665T3 PL 1667665 T3 PL1667665 T3 PL 1667665T3 PL 04764591 T PL04764591 T PL 04764591T PL 04764591 T PL04764591 T PL 04764591T PL 1667665 T3 PL1667665 T3 PL 1667665T3
- Authority
- PL
- Poland
- Prior art keywords
- different
- active substances
- release profiles
- capsules
- drug
- Prior art date
Links
- 239000008188 pellet Substances 0.000 title abstract 3
- 239000002775 capsule Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 6
- 238000010521 absorption reaction Methods 0.000 abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 2
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 235000010755 mineral Nutrition 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 239000000419 plant extract Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000011573 trace mineral Substances 0.000 abstract 1
- 235000013619 trace mineral Nutrition 0.000 abstract 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03019577 | 2003-09-03 | ||
| EP04764591A EP1667665B1 (de) | 2003-09-03 | 2004-08-28 | Kapseln enthaltend wirkstoffpellets mit unterschiedlichen freisetzungsprofilen |
| PCT/EP2004/009617 WO2005023229A1 (de) | 2003-09-03 | 2004-08-28 | Kapsel enthaltend wirkstoffpellets mit unterschiedlichen freisetzungsprofilen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1667665T3 true PL1667665T3 (pl) | 2009-06-30 |
Family
ID=34259144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04764591T PL1667665T3 (pl) | 2003-09-03 | 2004-08-28 | Kapsułki zawierające peletki z substancją czynną z różnymi profilami uwalniania |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20050058704A1 (pl) |
| EP (1) | EP1667665B1 (pl) |
| JP (1) | JP4897483B2 (pl) |
| AT (1) | ATE419841T1 (pl) |
| BR (1) | BRPI0413201A (pl) |
| CA (1) | CA2537477C (pl) |
| CY (1) | CY1108950T1 (pl) |
| DE (1) | DE502004008834D1 (pl) |
| DK (1) | DK1667665T3 (pl) |
| ES (1) | ES2317024T3 (pl) |
| MX (1) | MXPA06002316A (pl) |
| PL (1) | PL1667665T3 (pl) |
| PT (1) | PT1667665E (pl) |
| RU (1) | RU2356540C2 (pl) |
| SI (1) | SI1667665T1 (pl) |
| UA (1) | UA87471C2 (pl) |
| WO (1) | WO2005023229A1 (pl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050053648A1 (en) * | 2003-09-08 | 2005-03-10 | Chalmers Anne Marie | Medication delivery device |
| BRPI0415242B8 (pt) * | 2003-10-10 | 2021-05-25 | Ethypharm Sa | microgrânulos de liberação gradual contendo extrato de gingko biloba e o processo para fabricar estes |
| US20060252831A1 (en) * | 2005-05-06 | 2006-11-09 | Christopher Offen | Method for the treatment of magnesium and potassium deficiencies |
| US20060252830A1 (en) * | 2005-05-06 | 2006-11-09 | Brandon Stephen F | Method for the treatment of magnesium and potassium deficiencies |
| DE102006006532B4 (de) | 2006-02-10 | 2007-11-08 | Biogenerics Pharma Gmbh | Pharmazeutische Zubereitung |
| CA2648278C (en) * | 2006-04-03 | 2019-05-28 | Isa Odidi | Drug delivery composition |
| PL2120878T3 (pl) * | 2007-02-09 | 2015-01-30 | Alphapharm Pty Ltd | Postać dawkowania zawierająca dwa czynne składniki farmaceutyczne o różnych postaciach fizycznych |
| EP2136821A4 (en) * | 2007-03-12 | 2013-01-16 | Pipex Pharmaceuticals Inc | ZINC-BASED ORAL INGREDIENTS USEFUL TO DECREASE SAFE COPPER ABSORPTION AND FREE COPPER LEVELS |
| PL3050568T3 (pl) | 2007-03-13 | 2021-06-14 | Jds Therapeutics, Llc | Sposoby i kompozycje do przedłużonego uwalniania chromu |
| WO2009002867A2 (en) | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
| AU2007362356A1 (en) * | 2007-12-12 | 2009-06-18 | Northern Innovations And Formulations Corp. | Particles in a capsule |
| US8445020B2 (en) | 2008-05-19 | 2013-05-21 | Pharmalyte Solutions, Llc | High-loading, controlled-release magnesium oral dosage forms and methods of making and using same |
| WO2010010579A1 (en) * | 2008-07-19 | 2010-01-28 | Lupin Limited | Multiple unit dosage form of niacin |
| US20130011469A1 (en) | 2009-07-23 | 2013-01-10 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Krill oil and carotenoid composition, associated method and delivery system |
| CN102038691B (zh) * | 2009-10-12 | 2014-06-11 | 杭州赛利药物研究所有限公司 | 一种维生素氨基酸的复合制剂及其制备方法 |
| DE102010022174A1 (de) * | 2010-05-12 | 2011-11-17 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Neue Darreichungsformen für Cineol |
| WO2014071176A1 (en) * | 2012-11-02 | 2014-05-08 | Disilvestro Robert | Nutritional supplements including meal replacements and related methods |
| US20150104539A1 (en) * | 2013-10-15 | 2015-04-16 | Via Naturally, LLC | Citrated folic acid compositions and methods for delivering folic acid to usp dissolution specifications |
| CN109069532A (zh) | 2016-02-11 | 2018-12-21 | 营养21有限责任公司 | 含铬组合物用于改善健康和健身 |
| WO2018035030A1 (en) * | 2016-08-15 | 2018-02-22 | Corr-Jensen Inc. | Time release fat-soluble actives |
| ES2695503B2 (es) * | 2017-06-30 | 2020-05-08 | Pharmalink S L | Formulaciones encapsuladas |
| KR102368654B1 (ko) * | 2020-04-17 | 2022-02-28 | 주식회사 청안오가닉스 | 녹차 카테킨을 포함하는 경구용 캡슐 |
| BR112023000264A2 (pt) * | 2020-07-09 | 2023-01-31 | Dsm Ip Assets Bv | Método para aumentar a população de coprococcus spp. no microbioma intestinal |
| CN111821266B (zh) * | 2020-07-17 | 2021-09-14 | 迪沙药业集团有限公司 | 一种牛磺酸缓释组合物及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS50151874A (pl) * | 1974-05-16 | 1975-12-06 | ||
| JPS50151874U (pl) * | 1974-06-01 | 1975-12-17 | ||
| JPS5347513A (en) * | 1976-10-14 | 1978-04-28 | Meiji Seika Kaisha Ltd | Preparation of enzymatic agent |
| US4507276A (en) * | 1982-08-20 | 1985-03-26 | Bristol-Myers Company | Analgesic capsule |
| JPS5982311A (ja) * | 1982-11-04 | 1984-05-12 | Shionogi & Co Ltd | セフアレキシン持効性製剤 |
| US5260068A (en) * | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
| JP3459421B2 (ja) * | 1992-12-23 | 2003-10-20 | サイテック ソチエタ レスポンサビリタ リミテ | 調節された開放医薬形の調製法及びそのようにして得られた医薬形 |
| FR2705233B1 (fr) * | 1993-05-14 | 1996-07-12 | Atheliapharm Sa | Nouvelles formes galéniques permettant la chronolibération différentielle d'associations de micronutriments utilisés en diététique et/ou thérapeutique. |
| US5837284A (en) * | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
| IT1283478B1 (it) * | 1996-07-22 | 1998-04-21 | Roberto Valducci | Composizioni per integrazione nutrizionale comprendenti vitamine idrosolubili a rilascio prolungato |
| JP2000507613A (ja) * | 1996-11-01 | 2000-06-20 | アイレックス・オンコロジー・インコーポレイテッド | Ｄｆｍｏ含有持続放出配合物 |
| SE9704870D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
| ATE253354T1 (de) * | 1999-02-23 | 2003-11-15 | Yuhan Corp | Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen |
| WO2000069420A1 (en) * | 1999-05-14 | 2000-11-23 | Coraltis Ltd. | Pulse-delivery oral compositions |
| US6258846B1 (en) * | 1999-06-01 | 2001-07-10 | Drugtech Corporation | Nutritional supplements |
-
2004
- 2004-08-28 SI SI200431059T patent/SI1667665T1/sl unknown
- 2004-08-28 MX MXPA06002316A patent/MXPA06002316A/es active IP Right Grant
- 2004-08-28 JP JP2006525084A patent/JP4897483B2/ja not_active Expired - Fee Related
- 2004-08-28 AT AT04764591T patent/ATE419841T1/de active
- 2004-08-28 CA CA2537477A patent/CA2537477C/en not_active Expired - Fee Related
- 2004-08-28 DE DE502004008834T patent/DE502004008834D1/de not_active Expired - Lifetime
- 2004-08-28 PT PT04764591T patent/PT1667665E/pt unknown
- 2004-08-28 DK DK04764591T patent/DK1667665T3/da active
- 2004-08-28 WO PCT/EP2004/009617 patent/WO2005023229A1/de not_active Ceased
- 2004-08-28 UA UAA200603476A patent/UA87471C2/uk unknown
- 2004-08-28 PL PL04764591T patent/PL1667665T3/pl unknown
- 2004-08-28 BR BRPI0413201-7A patent/BRPI0413201A/pt not_active Application Discontinuation
- 2004-08-28 RU RU2006110549/15A patent/RU2356540C2/ru not_active IP Right Cessation
- 2004-08-28 ES ES04764591T patent/ES2317024T3/es not_active Expired - Lifetime
- 2004-08-28 EP EP04764591A patent/EP1667665B1/de not_active Expired - Lifetime
- 2004-09-02 US US10/932,839 patent/US20050058704A1/en not_active Abandoned
-
2009
- 2009-03-31 CY CY20091100378T patent/CY1108950T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2537477C (en) | 2013-05-14 |
| RU2006110549A (ru) | 2007-10-10 |
| MXPA06002316A (es) | 2006-05-19 |
| JP2007504189A (ja) | 2007-03-01 |
| BRPI0413201A (pt) | 2006-10-03 |
| CA2537477A1 (en) | 2005-03-17 |
| RU2356540C2 (ru) | 2009-05-27 |
| WO2005023229A1 (de) | 2005-03-17 |
| CY1108950T1 (el) | 2014-07-02 |
| PT1667665E (pt) | 2009-02-13 |
| DK1667665T3 (da) | 2009-05-04 |
| SI1667665T1 (sl) | 2009-06-30 |
| UA87471C2 (uk) | 2009-07-27 |
| EP1667665A1 (de) | 2006-06-14 |
| DE502004008834D1 (de) | 2009-02-26 |
| US20050058704A1 (en) | 2005-03-17 |
| JP4897483B2 (ja) | 2012-03-14 |
| ATE419841T1 (de) | 2009-01-15 |
| ES2317024T3 (es) | 2009-04-16 |
| EP1667665B1 (de) | 2009-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1667665T1 (sl) | Kapsule, ki vsebujejo pelete z učinkovinami z različnimi profili sproščanja | |
| KR20190026648A (ko) | 선택적 위장관 전달을 위한 조성물 및 방법 | |
| WO2011116139A3 (en) | Improved pharmaceutical compositions comprising cck- 8 and methods of delivery | |
| WO2007067044A3 (en) | Modified active-ingredient-containing pellets/capsules | |
| IL190646A (en) | Multifunctional June Liquid Preparations, Including Pharmaceutical, Bioactive, Nutritional and Energetic Vehicles and Method for Preparing | |
| MX2009011275A (es) | Una composicion de microesferas biodegradables adecuadas para la liberacion controlada de peptido de control de la glucosa y formulacion de la misma. | |
| WO2003043631A3 (en) | Method for identification of tumor targeting enzymes | |
| HK1047537A1 (zh) | 多元藥物劑型 | |
| WO2006125620A3 (en) | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture | |
| WO2010032140A3 (en) | Pharmaceutical compositions and related methods of delivery | |
| ATE329579T1 (de) | Feste dispersion mit ritonavir, fenofibrat oder griseofulvin | |
| WO2001089571A3 (en) | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | |
| WO2007122635A3 (en) | Controlled release formulation comprising anti-epileptic drugs | |
| ID26741A (id) | Proses pembuatan beadlet yang mengandung bahan yang dapat larut dalam lemak | |
| EP2695617A3 (en) | Vitamin D glycosides and sulfates for treating intestinal diseases | |
| NO20024237L (no) | Farmasöytiske formuleringer | |
| AR024564A1 (es) | Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico | |
| Zhang et al. | Fabrication of phosphatidylcholine-EGCG nanoparticles with sustained release in simulated gastrointestinal digestion and their transcellular permeability in a Caco-2 monolayer model | |
| BR0309851A (pt) | Processos e formulações para aperfeiçoamento de absorção e biodisponibilidade gastrointestinal de drogas hidrofóbicas | |
| IL174655A0 (en) | Drug containing (2r)-2-propyloctanoic acid as the active ingredient | |
| GB2443793B (en) | Product, method of manufacture and use | |
| BRPI0615195A8 (pt) | preparação farmacêutica, embalagem, e, métodos para tratar doença gastrintestinal, para fabricar uma cápsula e para testar dissolução de cápsulas de balsalazida. | |
| JP4744297B2 (ja) | 糖脂質含有組成物、その用途およびその製造方法 | |
| WO2002080981A3 (en) | Polynucleotide binding complexes comprising sterols and saponins | |
| IL174691A0 (en) | Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient |